Cardiorenal | List of Frontiers open access articles

Original Research

Published on 18 Mar 2022

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome

in Renal Pharmacology

Cankun Zheng
Wanling Xuan
Zhenhuan Chen
Rui Zhang
Xiaoxia Huang
Yingqi Zhu
Siyuan Ma
Kaitong Chen
Lu Chen
Mingyuan He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.848310

6,398 views
18 citations

Mini Review

Published on 20 May 2022

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics

in General Cardiovascular Medicine

Edmund Y. M. Chung
Katie Trinh
Jennifer Li
Sebastian Hayden Hahn
Zoltan H. Endre
Natasha M. Rogers
Stephen I. Alexander

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.868658

15,371 views
36 citations

Systematic Review

Published on 28 Jun 2022

Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review

in General Cardiovascular Medicine

Ling Lin
Yangqin Chen
Dongwan Han
Andrew Yang
Amanda Y. Wang
Wenjie Qi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.915533

4,719 views
9 citations

Review

Published on 26 Oct 2022

Current considerations for heart-kidney transplantation

in Abdominal Transplantation

Syed Adeel Ahsan
Lamees I. El Nihum
Priya Arunachalam
Nina Manian
Qasim Al Abri
Ashrith Guha

Frontiers in Transplantation

doi 10.3389/frtra.2022.1022780

3,909 views
1 citation

Review

Published on 06 Feb 2024

Emerging role of antidiabetic drugs in cardiorenal protection

in Cardiovascular and Smooth Muscle Pharmacology

Wen-Jia Fu
Jin-Ling Huo
Zi-Hui Mao
Shao-Kang Pan
Dong-Wei Liu
Zhang-Suo Liu
Peng Wu
Zhong-Xiuzi Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1349069

7,615 views
14 citations

Review

Published on 28 Jan 2021

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes

in Cardiovascular Therapeutics

Lama A. Ammar
Mohamad I. Nahlawi
Nizar W. Shayya
Hilda E. Ghadieh
Nadim S. Azar
Frédéric Harb
Assaad A. Eid

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.630917

5,571 views
5 citations

Review

Published on 14 Dec 2021

Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment

in Heart Failure and Transplantation

Kang Fu
Yue Hu
Hui Zhang
Chen Wang
Zongwei Lin
Huixia Lu
Xiaoping Ji

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.760152

9,954 views
21 citations

Review

Published on 19 Dec 2023

Consensus document on palliative care in cardiorenal patients

in General Cardiovascular Medicine

Clara Bonanad
Juan M. Buades
Juan Pablo Leiva
Rafael De la Espriella
Marta Cobo Marcos
Julio Núñez
Helena García-Llana
Lorenzo Facila
Rosa Sánchez
Laura Rodríguez-Osorio

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1225823

8,987 views
1 citation

Review

Published on 25 May 2021

Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease

in Nephrology

Luis D'Marco
María Jesús Puchades
Nayara Panizo
María Romero-Parra
Lorena Gandía
Elena Giménez-Civera
Elisa Pérez-Bernat
Miguel Gonzalez-Rico
José Luis Gorriz

Frontiers in Medicine

doi 10.3389/fmed.2021.640814

10,408 views
20 citations

Review

Published on 10 May 2023

Cardiorenal syndrome and diabetes: an evil pairing

in General Cardiovascular Medicine

Ana Belén Méndez Fernández
Ander Vergara Arana
Aleix Olivella San Emeterio
Maria Antonieta Azancot Rivero
Toni Soriano Colome
Maria Jose Soler Romeo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1185707

15,388 views
17 citations

Review

Published on 28 Apr 2023

Targeting immunometabolism during cardiorenal injury: roles of conventional and alternative macrophage metabolic fuels

in Metabolic Physiology

Alan J. Mouton
Jussara M. do Carmo
Alexandre A. da Silva
Ana C. M. Omoto
John E. Hall

Frontiers in Physiology

doi 10.3389/fphys.2023.1139296

4,840 views
2 citations

Original Research

Published on 07 Jan 2025

Psychological wellbeing and treatment adherence among cardio-renal syndrome patients in Yemen: a cross section study

in Nephrology

Adel Omar Laradhi
Yan Shan
Mohamed Elsayed Allawy

Frontiers in Medicine

doi 10.3389/fmed.2024.1439704

2,421 views
3 citations

Perspective

Published on 22 Feb 2024

Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases

in Clinical Diabetes

Xiaoqian Zhang
Jiale Zhang
Yan Ren
Ranran Sun
Xu Zhai

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1368481

9,735 views
34 citations

Review

Published on 21 Nov 2023

From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge

in Cardiovascular and Smooth Muscle Pharmacology

Jialun Zhang
Peining Zhu
Siyu Li
Yufei Gao
Yue Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291922

7,197 views
23 citations

Original Research

Published on 23 May 2022

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

in Cardiovascular Genetics and Systems Medicine

Anzhu Wang
Zhendong Li
Sun Zhuo
Feng Gao
Hongwei Zhang
Zhibo Zhang
Gaocan Ren
Xiaochang Ma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.857952

7,596 views
16 citations

Review

Published on 14 Jun 2024

The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials

in Nephrology

Mustafa Arici
Bulent Altun
Mustafa Araz
Aysegul Atmaca
Tevfik Demir
Tevfik Ecder
Galip Guz
Dilek Gogas Yavuz
Alaattin Yildiz
Temel Yilmaz

Frontiers in Medicine

doi 10.3389/fmed.2024.1384454

14,103 views
6 citations

Articles

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics

Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review

Current considerations for heart-kidney transplantation

Emerging role of antidiabetic drugs in cardiorenal protection

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes

Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment

Consensus document on palliative care in cardiorenal patients

Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease

Cardiorenal syndrome and diabetes: an evil pairing

Targeting immunometabolism during cardiorenal injury: roles of conventional and alternative macrophage metabolic fuels

Psychological wellbeing and treatment adherence among cardio-renal syndrome patients in Yemen: a cross section study

Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases

From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology

The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials